Eyenovia ( (EYEN) ) just unveiled an announcement.
Eyenovia, Inc. has announced a registered direct offering aimed at raising approximately $4 million by selling shares and warrants to a healthcare-focused institutional investor. The offering price is set at $0.46 per share, with warrants exercisable at $0.50 starting six months after issuance and expiring in five years. The company plans to use the proceeds for commercialization of its products, funding a clinical study on pediatric myopia, and general corporate purposes, which may include debt repayment. The offering is expected to close by September 30, 2024, with A.G.P./Alliance Global Partners and Brookline Capital Markets acting as the placement agents.
See more data about EYEN stock on TipRanks’ Stock Analysis page.
